Everest Biolabs
United States · Biotech
Automated instruments and assays that help biomedical researchers isolate and analyze extracellular vesicles from biological samples.
Making extracellular-vesicle research more reproducible
Everest Biolabs supplies automated systems and consumables for isolating and analyzing extracellular vesicles, small particles studied for their role in cell communication and disease biomarkers. Its Ascent system automates size-exclusion chromatography workflows, while the higher-throughput Summit instrument processes multiple samples in parallel; the company also sells isolation columns and ELISA kits for quantification.
These tools are designed for researchers working with complex biofluids, where abundant proteins and other material can obscure vesicle measurements. Everest’s product range combines sample preparation and measurement so laboratories can run more repeatable EV studies and scale up biomarker research.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| SBIR Direct-to-Phase II grant | $2.1M | National Institute of General Medical Sciences — Participant |